BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32470618)

  • 1. Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients.
    O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MD
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):461-470. PubMed ID: 32470618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphedema-associated comorbidities and treatment gap.
    Son A; O'Donnell TF; Izhakoff J; Gaebler JA; Niecko T; Iafrati MA
    J Vasc Surg Venous Lymphat Disord; 2019 Sep; 7(5):724-730. PubMed ID: 31248833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema.
    Lerman M; Gaebler JA; Hoy S; Izhakoff J; Gullett L; Niecko T; Karaca-Mandic P; O'Donnell T; Rockson SG
    J Vasc Surg; 2019 Feb; 69(2):571-580. PubMed ID: 29914829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manual lymphatic drainage for lymphedema following breast cancer treatment.
    Ezzo J; Manheimer E; McNeely ML; Howell DM; Weiss R; Johansson KI; Bao T; Bily L; Tuppo CM; Williams AF; Karadibak D
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD003475. PubMed ID: 25994425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes dataset.
    Karaca-Mandic P; Hirsch AT; Rockson SG; Ridner SH
    Br J Dermatol; 2017 Dec; 177(6):1699-1707. PubMed ID: 28573790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New advances in compression therapy for venous leg ulcers.
    Woo KY; Alavi A; Evans R; Despatis M; Allen J
    Surg Technol Int; 2013 Sep; 23():61-8. PubMed ID: 24081848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Manual Lymphatic Drainage Add Value in Reducing Suprafascial Fluid Accumulation and Skin Elasticity in Patients With Breast Cancer-Related Lymphedema?
    De Vrieze T; Gebruers N; Nevelsteen I; Thomis S; De Groef A; Tjalma WAA; Belgrado JP; Vandermeeren L; Monten C; Hanssens M; Asnong A; Dams L; Van der Gucht E; Heroes AK; Devoogdt N
    Phys Ther; 2022 Dec; 102(12):. PubMed ID: 36209432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of intermittent pneumatic compression as a substitute for manual lymphatic drainage in complete decongestive therapy in the treatment of breast cancer related lymphedema.
    Sanal-Toprak C; Ozsoy-Unubol T; Bahar-Ozdemir Y; Akyuz G
    Lymphology; 2019; 52(2):82-91. PubMed ID: 31525829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema.
    Brown JC; Cheville AL; Tchou JC; Harris SR; Schmitz KH
    Support Care Cancer; 2014 Jan; 22(1):135-43. PubMed ID: 24013569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home.
    Fife CE; Davey S; Maus EA; Guilliod R; Mayrovitz HN
    Support Care Cancer; 2012 Dec; 20(12):3279-86. PubMed ID: 22549506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic benefit of a novel dual-mode ambulatory compression device for treatment of chronic venous leg ulcers in a randomized clinical trial.
    Marston WA; Kirsner RS; Tallis A; Hanft JR; Walters J; Farber A;
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1031-1040.e1. PubMed ID: 32451241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical therapies in the decongestive treatment of lymphedema: A randomized, non-inferiority controlled study.
    Forner-Cordero I; Muñoz-Langa J; DeMiguel-Jimeno JM; Rel-Monzó P
    Clin Rehabil; 2021 Dec; 35(12):1743-1756. PubMed ID: 34514891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex Decongestive Therapy in Breast Cancer-Related Lymphedema: Does Obesity Affect the Outcome Negatively?
    Duyur Cakıt B; Pervane Vural S; Ayhan FF
    Lymphat Res Biol; 2019 Feb; 17(1):45-50. PubMed ID: 30281384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Surveillance with Compression for Subclinical Lymphedema: Symptoms, Skin, and Quality-of-Life Outcomes.
    Dietrich MS; Gaitatzis K; Koelmeyer L; Boyages J; Abramson VG; McLaughlin SA; Ngui N; Elder E; French J; Hsu J; Hughes TM; Stolldorf DP; Shah C; Ridner SH
    Lymphat Res Biol; 2023 Jun; 21(3):304-313. PubMed ID: 36126315
    [No Abstract]   [Full Text] [Related]  

  • 15. Advances in the prevention and treatment of breast cancer-related lymphedema.
    Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
    Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Treatment of Breast Cancer-related Lymphedema: A Descriptive Review of the State of the Art.
    Marchica P; D'Arpa S; Magno S; Rossi C; Forcina L; Capizzi V; Oieni S; Amato C; Piazza D; Gebbia V
    Anticancer Res; 2021 Jul; 41(7):3233-3246. PubMed ID: 34230117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and efficiency of a new therapeutic approach based on activity-oriented proprioceptive antiedema therapy (TAPA) for edema reduction and improved occupational performance in the rehabilitation of breast cancer-related arm lymphedema in women: a controlled, randomized clinical trial.
    Muñoz-Alcaraz MN; Pérula-de-Torres LÁ; Serrano-Merino J; Jiménez-Vílchez AJ; Olmo-Carmona MV; Muñoz-García MT; Bartolomé-Moreno C; Oliván-Blázquez B; Magallón-Botaya R
    BMC Cancer; 2020 Nov; 20(1):1074. PubMed ID: 33167921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs.
    Brayton KM; Hirsch AT; O Brien PJ; Cheville A; Karaca-Mandic P; Rockson SG
    PLoS One; 2014; 9(12):e114597. PubMed ID: 25470383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lymphedema in the management of venous leg ulcers.
    Moon T; O'Donnell TF; Weycker D; Iafrati M
    Phlebology; 2023 Oct; 38(9):613-621. PubMed ID: 37647614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy on management of breast cancer-related lymphedema.
    Cacchio A; Prencipe R; Bertone M; De Benedictis L; Taglieri L; D'Elia E; Centoletti C; Di Carlo G
    Support Care Cancer; 2019 Apr; 27(4):1471-1480. PubMed ID: 30343411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.